IL73034A - Pharmaceutical composition containing refined detoxified endotoxin and a pyridine-soluble extract of a microorganism - Google Patents

Pharmaceutical composition containing refined detoxified endotoxin and a pyridine-soluble extract of a microorganism

Info

Publication number
IL73034A
IL73034A IL73034A IL7303484A IL73034A IL 73034 A IL73034 A IL 73034A IL 73034 A IL73034 A IL 73034A IL 7303484 A IL7303484 A IL 7303484A IL 73034 A IL73034 A IL 73034A
Authority
IL
Israel
Prior art keywords
microorganism
pharmaceutical composition
pyridine
soluble extract
composition containing
Prior art date
Application number
IL73034A
Other languages
English (en)
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of IL73034A publication Critical patent/IL73034A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
IL73034A 1983-09-23 1984-09-23 Pharmaceutical composition containing refined detoxified endotoxin and a pyridine-soluble extract of a microorganism IL73034A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/535,037 US4663306A (en) 1983-09-23 1983-09-23 Pyridine-soluble extract-refined detoxified endotoxin composition and use

Publications (1)

Publication Number Publication Date
IL73034A true IL73034A (en) 1988-11-15

Family

ID=24132594

Family Applications (1)

Application Number Title Priority Date Filing Date
IL73034A IL73034A (en) 1983-09-23 1984-09-23 Pharmaceutical composition containing refined detoxified endotoxin and a pyridine-soluble extract of a microorganism

Country Status (23)

Country Link
US (1) US4663306A (de)
JP (1) JPS60120817A (de)
KR (1) KR870000843B1 (de)
AT (1) AT385659B (de)
AU (1) AU566234B2 (de)
BE (1) BE900650A (de)
CA (1) CA1244765A (de)
CH (1) CH664897A5 (de)
DE (1) DE3434766C2 (de)
DK (1) DK446684A (de)
ES (1) ES8608872A1 (de)
FI (1) FI843716L (de)
FR (1) FR2552326B1 (de)
GB (1) GB2149301B (de)
HU (1) HU192585B (de)
IL (1) IL73034A (de)
IN (1) IN157240B (de)
IT (1) IT1179444B (de)
NL (1) NL8402902A (de)
NO (1) NO843776L (de)
NZ (1) NZ209635A (de)
SE (1) SE8404707L (de)
ZA (1) ZA847405B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844894A (en) * 1984-07-12 1989-07-04 Ribi Immunochem Research Inc. Method of inhibiting the onset of septicemia and endotoxemia
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4929604A (en) * 1986-05-28 1990-05-29 Board Of Regents, The University Of Texas System Lipopolysaccharides of reduced toxicity and the production thereof
DE69429521T2 (de) * 1993-08-27 2002-07-18 Vetrepharm, Inc. Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
BE1007823A3 (fr) * 1993-12-10 1995-10-31 Anda Biolog Sa Utilisation d'une composition comprenant au moins un antigene et/ou un ou plusieurs fragments de cet antigene pour l'obtention d'un medicament destine au traitement et/ou a la prevention du cancer.
US5976580A (en) 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
DE19710255A1 (de) * 1997-03-13 1998-09-17 Henkel Ecolab Gmbh & Co Ohg Verwendung einer Lösung zur Desaktivierung von Endotoxinen
JP4335435B2 (ja) 1997-08-05 2009-09-30 バイオニケ ライフ サイエンシーズ インコーポレイテッド 細胞増殖および細胞死を調節する組成物および方法
US6019985A (en) * 1998-02-27 2000-02-01 Munova Corporation Immunostimulation methods for providing disease protection in poultry
CN1230184C (zh) * 1998-07-16 2005-12-07 东市郎 以细菌的菌体成分为有效成分的癌免疫治疗用制剂
CZ20022372A3 (cs) * 1999-12-13 2002-11-13 Bioniche Life Sciences Inc. Terapeuticky pouľitelné syntetické oligonukleotidy
CA2395493C (en) * 1999-12-28 2010-06-22 Bioniche Life Sciences Inc. Hyaluronic acid in the treatment of cancer
CZ200372A3 (cs) * 2000-07-11 2003-05-14 Bayer Aktiengesellschaft Použití kmenů Parapoxvirus ovis pro výrobu léku k léčení orgánových fibróz
WO2003074079A1 (fr) * 2002-03-05 2003-09-12 Cell-Medicine, Inc. Adjuvant immunologique a base de tissus solidifies
JP4726485B2 (ja) * 2002-08-02 2011-07-20 大日本住友製薬株式会社 細菌細胞壁骨格成分製剤
FR2848223B1 (fr) * 2002-12-09 2005-02-25 Centre Nat Rech Scient Nouveau procede d'isolement des endotoxines.
WO2005023277A1 (fr) * 2003-09-05 2005-03-17 Shenyang Sunbellcom Bio-Pharmaceutical Co., Ltd. Composition a la base de squelettes de parois de cellules de nocardia rouge procede de preparation et son utilisation therapeutique pour traiter l'erosion cervicale
EP1741438A4 (de) * 2004-04-22 2009-08-26 Dainippon Sumitomo Pharma Co Pharmazeutisches präparat mit einer bakterienzellwand-skelett-komponente
EA032326B1 (ru) 2013-04-18 2019-05-31 Иммьюн Дизайн Корп. Монотерапия gla для применения в лечении рака
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
EP3158054B1 (de) 2014-06-17 2025-02-19 Crown Laboratories, Inc. Gentechnisch modifizierte bakterien und verfahren zur genetischen modifikation von bakterien
US11504404B2 (en) 2016-02-24 2022-11-22 Crown Laboratories, Inc. Skin probiotic formulation
EP3668957A4 (de) * 2017-08-17 2021-06-02 University of Delaware Zusammensetzungen auf furanbasis und verfahren zu ihrer herstellung
AU2021297215A1 (en) 2020-06-23 2023-02-09 Crown Laboratories, Inc. Probiotic skin formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7308450A (de) * 1972-06-20 1973-12-27
FR2269962B1 (de) * 1974-05-06 1978-02-03 Anvar
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白ｗｅｎａｃ及びその製造法
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1209504A (en) * 1982-06-30 1986-08-12 John L. Cantrell Pyridine soluble extract of a microorganism

Also Published As

Publication number Publication date
FI843716A7 (fi) 1985-03-24
US4663306A (en) 1987-05-05
ES536167A0 (es) 1986-07-16
HU192585B (en) 1987-06-29
DE3434766A1 (de) 1986-04-30
NZ209635A (en) 1989-01-27
IN157240B (de) 1986-02-15
DE3434766C2 (de) 1987-05-14
JPS6254775B2 (de) 1987-11-17
AU3340084A (en) 1985-03-28
IT1179444B (it) 1987-09-16
BE900650A (fr) 1985-03-21
HUT35521A (en) 1985-07-29
JPS60120817A (ja) 1985-06-28
DK446684A (da) 1985-03-24
IT8448894A0 (it) 1984-09-24
GB2149301B (en) 1988-06-22
FR2552326B1 (fr) 1988-05-13
KR870000843B1 (ko) 1987-04-25
ES8608872A1 (es) 1986-07-16
GB2149301A (en) 1985-06-12
AU566234B2 (en) 1987-10-15
CH664897A5 (de) 1988-04-15
SE8404707D0 (sv) 1984-09-20
ATA302384A (de) 1987-10-15
FI843716A0 (fi) 1984-09-21
ZA847405B (en) 1985-05-29
AT385659B (de) 1988-05-10
SE8404707L (sv) 1985-03-24
NO843776L (no) 1985-03-25
FI843716L (fi) 1985-03-24
CA1244765A (en) 1988-11-15
FR2552326A1 (fr) 1985-03-29
KR850002404A (ko) 1985-05-13
GB8423993D0 (en) 1984-10-31
NL8402902A (nl) 1985-04-16
DK446684D0 (da) 1984-09-19

Similar Documents

Publication Publication Date Title
IL73034A (en) Pharmaceutical composition containing refined detoxified endotoxin and a pyridine-soluble extract of a microorganism
GB2210557B (en) Vaccine containing tumor antigens and refined detoxified endotoxin as an adjuvant.
JPS5791915A (en) Novel lipid composition useful for dietetics, resuscitation and treatment
IT1164626B (it) Procedimento per il ricupero di ifn-b umano da microorganismi produttori trasformati
DE3370482D1 (en) Substituted 8-phenylxanthines
NZ192991A (en) Preparation of purified protein hydrolysate
JPS57181043A (en) Arylcyclobutylamine derivative as medicine and manufacture
AU575588B2 (en) Extraction of human-y interferon of 18 kdalton using the protease inhibitor guanidine-hcp
MTP924B (en) Homogenous human immune interferom and process therefor
IL68255A0 (en) Actinomycete fungus strains and methods for the control of fungus diseases in plants using the same
AU555073B2 (en) Post expansion heat treatment of tobacco
JPS57169482A (en) Imidazopyrimidine derivative and application to medicine
AU591901B2 (en) Process for the in vitro immunization of human splenocytes against tumor associated antigens
AU1308288A (en) Method to stimulate the immune response to specific antigens
FR2550945B1 (fr) Compositions d'endotoxines purifiees et leur application pharmacologique
AU7121487A (en) Methods and compositions relating to regression-associated antigens
AU558071B2 (en) Live vaccine for bovine babesiosis and method of preparation
GB2144129B (en) Antigens as immunostimulant adjuvants
PT85284A (fr) Procede de preparation de fractions antigeniques exocellulaires de bordetella pertussis et vaccin contre la co-ueluche contenant de telles fractions
SU1238290A1 (ru) Способ получения препарата для лечения желудочно-кишечных заболеваний
IL63338A0 (en) Vaccine against bacterial diseases and its preparation